Lab-Grown tumor cells could guide personalized brain cancer treatment

NCT ID NCT05532397

Recruiting now Knowledge-focused Sponsor: National University Hospital, Singapore Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 25 times

Summary

This study aims to see if a lab-grown model of a patient's brain tumor can help doctors choose the most effective drug combination when the tumor returns. Ten adults with recurrent high-grade glioma will have a tumor sample taken to create a mini-tumor in the lab, which is then tested with many drugs. The best drug combination is then given to the patient. The main goal is to see if this approach can keep the tumor from growing for at least six months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOMA, ASTROCYTIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Department of Hematology-Oncology, National University Hospital
RECRUITING

Singapore, 119074, Singapore

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Ng Teng Fong General Hospital
NOT_YET_RECRUITING

Singapore, 609606, Singapore

Contact Phone: •••-•••-••••

Contact

Conditions

Explore the condition pages connected to this study.

GLIOMA, ASTROCYTIC